Skip to main content
Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.1080
+0.0136 (14.41%)
May 14, 2025, 11:01 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '18
Novel Integrated Drug and Drug Delivery Solutions
1.56M
Log In
Log In
Log In
Novel Integrated Drug and Drug Delivery Solutions Growth
14.31%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '18
United States
1.56M
Log In
Log In
Log In
United States Growth
14.31%
Log In
Log In
Log In